Highland Investment Advisors’s Boston Scientific BSX Stock Holding History

Highland Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$512	Buy	+12	New	+$652	﹤0.01%	577

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Highland Investment Advisors's BSX Position: Q2 2026 in Review

Highland Investment Advisors opened a new position in Boston Scientific (BSX) in Q2 2026: 12 shares worth $512. The stake represents ﹤0.01% of the portfolio and ranks #577 among its holdings.

1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Highland Investment Advisors held 12 shares of Boston Scientific worth $512 as of Q2 2026.
Boston Scientific was a new Highland Investment Advisors position in Q2 2026.
Boston Scientific made up ﹤0.01% of Highland Investment Advisors's portfolio in Q2 2026, its #577 holding.
1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Highland Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.